Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
All content curated by
Published in Dermatology

Journal Scan / Research · February 21, 2022

Serum Cytokeratin 18 as a Marker for Extramammary Paget's Disease

Acta Dermato-Venereologica

 

Additional Info

Acta Dermato-Venereologica
Serum Cytokeratin 18 as a Metastatic and Therapeutic Marker for Extramammary Paget's Disease
Acta Derm Venereol 2022 Jan 26;102(xx)adv00636, M Urano-Takaoka, H Sumida, T Miyagawa, K Awaji, K Nagai, J Omatsu, T Miyake, S Sato

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading